Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Integral Molecular, Inc. - Product Pipeline Review - 2014

Published: Dec-2014 | Format: PDF | Global Markets Direct | Number of pages: 19 | Code: MRS - 18603


Global Markets Directs, Integral Molecular, Inc. Product Pipeline Review 2014, provides an overview of the Integral Molecular, Inc.s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Integral Molecular, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

The report provides brief overview of Integral Molecular, Inc. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Integral Molecular, Inc.s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the Integral Molecular, Inc.s pipeline products

Reasons to buy

Evaluate Integral Molecular, Inc.s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Integral Molecular, Inc. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Integral Molecular, Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Integral Molecular, Inc. and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Integral Molecular, Inc.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Integral Molecular, Inc. and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues

Table Of Content 

Table of Contents 2
List of Tables 3
List of Figures 3
Integral Molecular, Inc. Snapshot 4
Integral Molecular, Inc. Overview 4
Key Information 4
Key Facts 4
Integral Molecular, Inc.- Research and Development Overview 5
Key Therapeutic Areas 5
Integral Molecular, Inc.- Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products- Monotherapy 8
Integral Molecular, Inc.- Pipeline Products Glance 9
Integral Molecular, Inc.- Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
Discovery Products/Combination Treatment Modalities 10
Integral Molecular, Inc.- Drug Profiles 11
Monoclonal Antibodies to Inhibit Viral E1/E2 Proteins for Chikungunya 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
Monoclonal Antibodies to Activate GLUT4 for Type 2 Diabetes 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Monoclonal Antibodies to Antagonize P2X3 Receptor for Pain 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Integral Molecular, Inc.- Pipeline Analysis 14
Integral Molecular, Inc.- Pipeline Products by Target 14
Integral Molecular, Inc.- Pipeline Products by Molecule Type 15
Integral Molecular, Inc.- Pipeline Products by Mechanism of Action 16
Integral Molecular, Inc.- Locations And Subsidiaries 17
Head Office 17

Appendix 18
Methodology 18
Coverage 18
Secondary Research 18
Primary Research 18
Expert Panel Validation 18
Contact Us 19
Disclaimer 19

List of Tables

Integral Molecular, Inc., Key Information 4
Integral Molecular, Inc., Key Facts 4
Integral Molecular, Inc.- Pipeline by Indication, 2014 6
Integral Molecular, Inc.- Pipeline by Stage of Development, 2014 7
Integral Molecular, Inc.- Monotherapy Products in Pipeline, 2014 8
Integral Molecular, Inc.- Preclinical, 2014 9
Integral Molecular, Inc.- Discovery, 2014 10
Integral Molecular, Inc.- Pipeline by Target, 2014 14
Integral Molecular, Inc.- Pipeline by Molecule Type, 2014 15
Integral Molecular, Inc.- Pipeline Products by Mechanism of Action, 2014 16

List of Figures

Integral Molecular, Inc. - Pipeline by Top 10 Indication, 2014 6
Integral Molecular, Inc. - Pipeline by Stage of Development, 2014 7
Integral Molecular, Inc. - Monotherapy Products in Pipeline, 2014 8
Integral Molecular, Inc. - Pipeline by Top 10 Target, 2014 14
Integral Molecular, Inc. - Pipeline by Top 10 Molecule Type, 2014 15
Integral Molecular, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014 16

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing